Xylo Technologies Ltd (XYLO)

Market Cap	2.38M
Revenue (ttm)	57.64M
Net Income (ttm)	-15.99M
Shares Out	732.07K
EPS (ttm)	-23.29
PE Ratio	n/a
Forward PE	0.96
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,299
Open	3.420
Previous Close	3.370
Day's Range	3.210 - 3.480
52-Week Range	2.700 - 10.430
Beta	1.46
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 1, 2024

About XYLO

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 84
• Stock Exchange: NASDAQ
• Ticker Symbol: XYLO
• Website: https://www.medigus.com

Financial Performance

In 2023, Xylo Technologies's revenue was $91.72 million, a decrease of -0.15% compared to the previous year's $91.86 million. Losses were -$16.03 million, 63.3% more than in 2022.

Financial numbers in USD